LLY and MRK Related Headlines
Go Back- Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight
- Large cap pharma defensive AI winner, says RBC as it backs Lilly & AbbVie
- Barclays launches U.S. biopharma coverage with four preferred picks
- This U.S. biotech stock is Bernstein's Top Pick for 2026
- FDA delays reviews of Sanofi's Tzield and Disc Medicine's bitopertin
- Trump to announce prescription drug price agreements
- Biotech Valuations Rise as New Clinical Platforms Show Progress
- Trump announcement on weight loss drugs scheduled for 11 A.M. Thursday; price to drop under $150/mo - CBS
- US Pausing Pharma Duties While Negotiations Ongoing - Politico
- Trump on deal with Pfizer: we're going to be paying the lowest price, other drugmakers will commit in coming weeks
- Bernstein on AmericasMedicines.com: 'The Noise Starts, But Not (Yet) from Trump'
- Trump: tariffs will get countries to agree to drug pricing plan
- Raymond James Comments on FDA and HHS Reforms for DTC Pharma Advertising
- Jefferies: 'We highlight multiple de-risked or commercial-stage names that we think have promising M&A potential'
LLY and MRK Related Press Releases
Go Back- Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight
- Biotech Valuations Rise as New Clinical Platforms Show Progress
